Feinstein Institutes’ Researcher Shares Concerns About Embryo Screening

Dr. Todd Lencz, and others in the Ethics Committee of the International Society of Psychiatric Genetics, publish concerns about polygenic embryo screening in The Lancet Psychiatry MANHASSET, N.Y.–(BUSINESS WIRE)–Genetic testing has been part of the in vitro fertilization (IVF) process for three decades and allows parents to screen embryos for illnesses. Yet, a new technique … [Read more…]

AHF: $10 Million Needed Now to Fight Monkeypox and STDs in LA County

AHF thanks the Los Angeles County Board of Supervisors for proclaiming a state of emergency on monkeypox today; urges the Supervisors to immediately allocate $10M for monkeypox and STDs, and presses County health officials to develop and share their plan of action to handle the outbreak LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) today thanked the … [Read more…]

Pear Therapeutics to be Added to Russell US Index Series

BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), announced today that it will be added to the Russell US Index Series in conjunction with the September 2022 quarterly review, effective after the US market open on Monday, September 19, 2022. Russell indexes are widely … [Read more…]

Greenbrook TMS Reports Second Quarter Operational and Financial Results

TORONTO–(BUSINESS WIRE)–Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its second quarter 2022 (“Q2 2022”) operational and financial results. All values in this press release are in United States dollars, unless otherwise stated. SECOND QUARTER 2022 OPERATIONAL AND FINANCIAL HIGHLIGHTS Revenue for Q2 2022 increased by 4% to a record … [Read more…]

MedX Health Strengthens Its Senior Management Team

MedX Announces Tarek El Hoss as Sr. Vice President, Market Development and Sales MISSISSAUGA, Ontario–(BUSINESS WIRE)–$MDX #SkinCancer–MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce that Tarek El Hoss has been appointed as the Company’s Vice President, Market Development and Sales. Mr. El Hoss will oversee … [Read more…]

Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference

NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) will participate in the 2022 Wells Fargo Securities Healthcare Conference at the Encore Boston Harbor in Everett, MA on Wednesday, September 7th. Ashley McEvoy, Executive Vice President, Worldwide Chairman, MedTech will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time). This conference call will … [Read more…]

Axonics® Announces Proposed Public Offering of Common Stock

IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX) (“Axonics”), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that it has commenced a proposed underwritten public offering of 1,750,000 shares of its common stock. Axonics expects to grant the underwriter a 30-day option to … [Read more…]

Personalis Files Patent Infringement Lawsuit Against Foresight Diagnostics

MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that it filed a lawsuit against Foresight Diagnostics Inc. for infringement of Personalis’ U.S. Patent Nos. 10,450,611, 11,299,783, and 11,384,394. These patents are part of Personalis’ intellectual property portfolio in the field of whole genome-enabled, tumor-informed molecular residual disease … [Read more…]

Bicycle Therapeutics Announces Publication of Article in Bioconjugate Chemistry, Describing an Extension of its Proprietary Technology Platform Based on Bicyclic Peptides

CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that an article highlighting data using tris-Gold complexes to increase the chemical diversity of Bicycles, was published in Bioconjugate Chemistry. The article, titled “Gold-Mediated Multiple … [Read more…]

AtriCure Reports Second Quarter 2022 Financial Results

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced second quarter 2022 financial results. “We delivered a remarkable second quarter as we continue changing the standard of care for millions of patients globally,” said Michael … [Read more…]